Renal toxicity fluoroquinolone toxicity fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Kidney Kidney Tubules, Proximal Kidney Tubules Liver Feces

Organisms42

Streptococcus pneumoniae Escherichia coli Staphylococcus aureus Gram-Negative Bacteria Gram-Positive Bacteria Mycoplasma hominis Pseudomonas aeruginosa Mycobacterium tuberculosis Clostridium difficile Neisseria gonorrhoeae Salmonella typhi Rats, Sprague-Dawley Salmonella enterica Mycobacterium fortuitum Rats, Inbred F344 Bacteria, Anaerobic Bacteria Klebsiella pneumoniae Salmonella paratyphi A Campylobacter jejuni Campylobacter Enterobacteriaceae Gram-Positive Cocci Campylobacter coli Moraxella (Branhamella) catarrhalis Mycobacterium smegmatis Bacteroides fragilis Enterococcus faecalis Rats, Wistar Acinetobacter Salmonella Haemophilus influenzae Laurus Bartonella bacilliformis Staphylococcus Methicillin-Resistant Staphylococcus aureus Streptococcus pyogenes Salmonella typhimurium Serratia marcescens Dogs Mycobacterium Ureaplasma

Diseases44

Kidney Diseases Dermatitis, Phototoxic Fanconi Syndrome Gram-Negative Bacterial Infections Escherichia coli Infections Bacterial Infections Pneumococcal Infections Urinary Tract Infections Community-Acquired Infections Typhoid Fever Eye Infections, Bacterial Acute Kidney Injury Tuberculosis, Multidrug-Resistant Renal Insufficiency Dermatitis, Photoallergic Gonorrhea Cross Infection Neoplasms Pseudomonas Infections Paratyphoid Fever Campylobacter Infections Respiratory Tract Infections Gram-Positive Bacterial Infections Enterocolitis, Pseudomembranous Salmonella Infections Staphylococcal Infections Bacteremia Body Weight Extensively Drug-Resistant Tuberculosis Neutropenia Klebsiella Infections Pneumonia, Bacterial Lung Neoplasms Bronchitis, Chronic Tuberculosis Pneumonia, Pneumococcal Diarrhea Enterobacteriaceae Infections Streptococcal Infections Otitis Externa Poultry Diseases Clostridium Infections Pneumonia Corneal Ulcer

Chemicals and Drugs81

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Quinolines Enoxacin DNA Topoisomerases, Type II 4-Quinolones Nalidixic Acid Cisplatin Topoisomerase II Inhibitors Gentamicins Amphotericin B DNA, Bacterial Acetylglucosaminidase Fleroxacin Creatinine Macrolides Antitubercular Agents Ifosfamide Antineoplastic Agents Organophosphonates Ethylene Glycol Bacterial Proteins Chloroform beta-Lactams DNA Topoisomerases Aminoglycosides Organoplatinum Compounds Metallothionein Cyclosporine Dioxolanes Carboplatin Diphosphonates Anti-Infective Agents, Urinary Membrane Transport Proteins Cephalosporins Octreotide Antifungal Agents beta-Lactamases Organophosphorus Compounds Erythromycin Adenine Nitrofurantoin Etoposide Reserpine Organometallic Compounds Trimethoprim-Sulfamethoxazole Combination Ethambutol Multidrug Resistance-Associated Proteins Capreomycin Lactams Piperazines Streptogramin B Carbapenems Rifampin Ethidium Immunosuppressive Agents Culture Media Escherichia coli Proteins Ceftriaxone Fluorouracil Chloramphenicol Azithromycin Bacterial Outer Membrane Proteins Penicillins Tetracyclines Ampicillin Biological Markers Doxorubicin Doxycycline DNA, Superhelical

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Microbial Sensitivity Tests Toxicity Tests No-Observed-Adverse-Effect Level Administration, Oral Drug Administration Schedule Toxicity Tests, Acute Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Blood Urea Nitrogen Kidney Function Tests Drug Evaluation Area Under Curve Infusions, Intravenous Combined Modality Therapy Lethal Dose 50 Electrophoresis, Gel, Pulsed-Field Survival Analysis Sequence Analysis, DNA Radiometry Colony Count, Microbial Toxicity Tests, Chronic Amino Acid Substitution Polymerase Chain Reaction Body Weight Injections, Intravenous Organ Size Drug Therapy, Combination Ribotyping Risk Factors Disk Diffusion Antimicrobial Tests Retrospective Studies Antibiotic Prophylaxis Treatment Failure Reverse Transcriptase Polymerase Chain Reaction Culture Media Molecular Typing Follow-Up Studies Chromatography, High Pressure Liquid Maximum Tolerated Dose Bacterial Typing Techniques Models, Biological Chromatography, Supercritical Fluid Serotyping Serum Bactericidal Test

Phenomena and Processes34

Drug Resistance, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Dose-Response Relationship, Drug Mutation No-Observed-Adverse-Effect Level Time Factors Drug Resistance, Multiple Area Under Curve Genes, Bacterial Drug Interactions Lethal Dose 50 Tissue Distribution Amino Acid Substitution Body Weight Organ Size beta-Lactam Resistance Methicillin Resistance Plasmids Cephalosporin Resistance Genotype Structure-Activity Relationship Cell Survival Mutation, Missense Penicillin Resistance Point Mutation Phenotype Maximum Tolerated Dose Base Sequence Molecular Structure Amino Acid Sequence Microbial Viability Gene Expression Regulation, Bacterial DNA, Superhelical

Information Science4

Molecular Sequence Data Formularies, Hospital Base Sequence Amino Acid Sequence

Named Groups1

Health Care10

Treatment Outcome Drug Utilization Area Under Curve Survival Analysis Hospitals Risk Factors Retrospective Studies Treatment Failure Follow-Up Studies Hospitals, County

Geographicals3

United States Taiwan France

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Microbial Sensitivity Tests Drug Resistance, Bacterial Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Quinolines Drug Resistance, Microbial Kidney Diseases Kidney Enoxacin DNA Topoisomerases, Type II 4-Quinolones Drug Resistance, Multiple, Bacterial Toxicity Tests Streptococcus pneumoniae Nalidixic Acid Dose-Response Relationship, Drug Dermatitis, Phototoxic Cisplatin Topoisomerase II Inhibitors Mutation No-Observed-Adverse-Effect Level Administration, Oral Drug Administration Schedule Gentamicins Escherichia coli Fanconi Syndrome Toxicity Tests, Acute Amphotericin B Treatment Outcome Staphylococcus aureus Gram-Negative Bacteria DNA, Bacterial Acetylglucosaminidase Fleroxacin Antineoplastic Combined Chemotherapy Protocols Blood Urea Nitrogen Creatinine Macrolides Kidney Function Tests Antitubercular Agents Ifosfamide Gram-Positive Bacteria Gram-Negative Bacterial Infections Escherichia coli Infections Antineoplastic Agents Organophosphonates Ethylene Glycol Bacterial Infections Pneumococcal Infections Drug Evaluation Bacterial Proteins Drug Utilization Mycoplasma hominis Chloroform Pseudomonas aeruginosa beta-Lactams Time Factors DNA Topoisomerases Mycobacterium tuberculosis Urinary Tract Infections Kidney Tubules, Proximal Drug Resistance, Multiple Area Under Curve Infusions, Intravenous Community-Acquired Infections Clostridium difficile Typhoid Fever Eye Infections, Bacterial Aminoglycosides Acute Kidney Injury Neisseria gonorrhoeae Salmonella typhi Organoplatinum Compounds Metallothionein Rats, Sprague-Dawley Kidney Tubules Tuberculosis, Multidrug-Resistant Renal Insufficiency Salmonella enterica Cyclosporine Mycobacterium fortuitum Rats, Inbred F344 Bacteria, Anaerobic Dermatitis, Photoallergic Dioxolanes Carboplatin Bacteria Diphosphonates Anti-Infective Agents, Urinary

No FAQ available that match "renal toxicity fluoroquinolone toxicity fluoroquinolones"